The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +438.46% increase from the last price of 1.30.
The current consensus among 1 polled investment analysts is to Hold stock in Titan Pharmaceuticals Inc. This rating has held steady since May, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.26
Reporting Date Aug 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.